• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019-2021 年南京成人耐异烟肼和利福平敏感结核的危险因素。

Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019-2021.

机构信息

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 321 Zhongshan Road, Nanjing, Jiangsu Province, 210008, PR China.

Department of Tuberculosis, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 211132, China.

出版信息

BMC Infect Dis. 2024 May 22;24(1):511. doi: 10.1186/s12879-024-09404-y.

DOI:10.1186/s12879-024-09404-y
PMID:38773443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11110291/
Abstract

INTRODUCTION

This study aimed to analyze the risk factors associated with isoniazid-resistant and rifampicin-susceptible tuberculosis (Hr-TB) in adults.

METHOD

The clinical data of 1,844 adult inpatients diagnosed with culture-positive pulmonary tuberculosis (PTB) in Nanjing Second Hospital from January 2019 and December 2021 were collected. All culture positive strain from the patient specimens underwent drug susceptibility testing (DST). Among them, 166 patients with Hr-TB were categorized as the Hr-TB group, while the remaining 1,678 patients were classified as having drug-susceptible tuberculosis (DS-TB). Hierarchical logistic regression was employed for multivariate analysis to identify variables associated with Hr-TB.

RESULTS

Multivariate logistic regression analysis revealed that individuals with diabetes mellitus (DM) (OR 1.472, 95% CI 1.037-2.088, p = 0.030) and a history of previous tuberculosis treatment (OR 2.913, 95% CI 1.971-4.306, p = 0.000) were at higher risk of developing adult Hr-TB, with this risk being more pronounced in male patients. Within the cohort, 1,640 patients were newly treated, and among them, DM (OR 1.662, 95% CI 1.123-2.461, p = 0.011) was identified as risk factors for Hr-TB.

CONCLUSIONS

Diabetes mellitus is a risk factor for Hr-TB in adults, and the contribution of diabetes as a risk factor was more pronounced in the newly treatment or male subgroup. And previous TB treatment history is also a risk factor for Hr-TB in adults.

摘要

目的

本研究旨在分析成人耐异烟肼和利福平肺结核(Hr-TB)相关的危险因素。

方法

收集 2019 年 1 月至 2021 年 12 月在南京第二医院住院的 1844 例成人培养阳性肺结核(PTB)患者的临床资料。所有患者的培养阳性菌株均进行药物敏感性试验(DST)。其中,166 例 Hr-TB 患者归入 Hr-TB 组,其余 1678 例为耐多药肺结核(DS-TB)患者。采用多变量逻辑回归分析鉴定与 Hr-TB 相关的变量。

结果

多变量逻辑回归分析显示,患有糖尿病(DM)(OR 1.472,95%CI 1.037-2.088,p=0.030)和既往结核病治疗史(OR 2.913,95%CI 1.971-4.306,p=0.000)的个体发生成人 Hr-TB 的风险更高,且男性患者的风险更高。在该队列中,1640 例患者为新治疗患者,其中糖尿病(OR 1.662,95%CI 1.123-2.461,p=0.011)是 Hr-TB 的危险因素。

结论

糖尿病是成人 Hr-TB 的危险因素,且糖尿病作为危险因素的贡献在新治疗或男性亚组中更为显著。既往结核病治疗史也是成人 Hr-TB 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/11110291/4ef9a7fbb27b/12879_2024_9404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/11110291/4ef9a7fbb27b/12879_2024_9404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/11110291/4ef9a7fbb27b/12879_2024_9404_Fig1_HTML.jpg

相似文献

1
Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019-2021.2019-2021 年南京成人耐异烟肼和利福平敏感结核的危险因素。
BMC Infect Dis. 2024 May 22;24(1):511. doi: 10.1186/s12879-024-09404-y.
2
Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.耐多药结核病:埃塞俄比亚西北部梅泰马和西阿尔马奇霍地区的患病率及危险因素
BMC Infect Dis. 2015 Oct 26;15:461. doi: 10.1186/s12879-015-1202-7.
3
Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.接受结核病治疗患者中用于快速、直接利福平和异烟肼药敏试验的显微镜观察药敏试验的验证
Clin Microbiol Infect. 2014 Jun;20(6):536-41. doi: 10.1111/1469-0691.12401. Epub 2013 Nov 21.
4
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.南非应用基因型 [校正后的 geontype] MTBDRplus 扩大耐药结核病检测的影响:一项观察性队列研究。
PLoS One. 2012;7(11):e49898. doi: 10.1371/journal.pone.0049898. Epub 2012 Nov 30.
5
Effect of mycobacterial drug resistance patterns on patients' survival: a cohort study in Thailand.分枝杆菌耐药模式对患者生存的影响:泰国的一项队列研究。
Glob J Health Sci. 2013 Aug 22;5(6):60-72. doi: 10.5539/gjhs.v5n6p60.
6
Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.从埃塞俄比亚西北部戈贾姆东部地区两家公立医院的肺结核患者中分离出的结核分枝杆菌的患病率和耐药情况
BMC Public Health. 2015 Jun 20;15:572. doi: 10.1186/s12889-015-1933-9.
7
Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.埃塞俄比亚提格雷地区肺部耐多药结核病患者的特征:一项横断面研究。
PLoS One. 2020 Aug 14;15(8):e0236362. doi: 10.1371/journal.pone.0236362. eCollection 2020.
8
Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.泰国一家三级保健医院耐异烟肼结核病中的异烟肼和二线抗结核药物的共同耐药性。
Microbiol Spectr. 2024 Mar 5;12(3):e0346223. doi: 10.1128/spectrum.03462-23. Epub 2024 Feb 7.
9
Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.吡嗪酰胺可能改善氟喹诺酮类药物治疗耐多药结核病。
Antimicrob Agents Chemother. 2012 Nov;56(11):5465-75. doi: 10.1128/AAC.01300-12. Epub 2012 Aug 6.
10
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.沙特阿拉伯结核分枝杆菌对抗结核药物的耐药性不断增加。
Int J Antimicrob Agents. 2001 May;17(5):415-8. doi: 10.1016/s0924-8579(01)00298-9.

引用本文的文献

1
Isoniazid-resistant TB and associated factors in Ethiopia.埃塞俄比亚耐异烟肼结核病及其相关因素
Public Health Action. 2025 Jun 4;15(2):76-81. doi: 10.5588/pha.25.0002. eCollection 2025 Jun.
2
Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing.南京2型糖尿病成年患者中利福平敏感但异烟肼耐药结核病的危险因素
BMC Infect Dis. 2025 Mar 10;25(1):335. doi: 10.1186/s12879-025-10709-9.
3
Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990-2021: a systematic analysis for the Global Burden of Diseases 2021 study.

本文引用的文献

1
Trends of type 2 diabetes with pulmonary tuberculosis patients,2013-2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic.2013 - 2022年2型糖尿病合并肺结核患者的趋势以及2019冠状病毒病(COVID - 19)大流行后的变化。
Tuberculosis (Edinb). 2024 May;146:102499. doi: 10.1016/j.tube.2024.102499. Epub 2024 Feb 27.
2
Sex differences in type 2 diabetes.2 型糖尿病的性别差异。
Diabetologia. 2023 Jun;66(6):986-1002. doi: 10.1007/s00125-023-05891-x. Epub 2023 Mar 10.
3
A retrospective cohort study on the treatment outcomes and genotyping of isoniazid-resistant tuberculosis patients in Eastern China.
全球、区域和国家结核病负担及 204 个国家和地区 1990-2021 年可归因风险因素:全球疾病负担 2021 研究系统分析。
BMC Public Health. 2024 Nov 11;24(1):3111. doi: 10.1186/s12889-024-20664-w.
4
Correction: Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019-2021.更正:2019 - 2021年南京成人耐异烟肼且对利福平敏感结核病的危险因素
BMC Infect Dis. 2024 Jul 22;24(1):716. doi: 10.1186/s12879-024-09632-2.
一项关于华东地区耐异烟肼结核患者治疗效果和基因分型的回顾性队列研究。
J Glob Antimicrob Resist. 2022 Sep;30:335-339. doi: 10.1016/j.jgar.2022.07.003. Epub 2022 Jul 8.
4
The 2021 WHO catalogue of complex mutations associated with drug resistance: A genotypic analysis.《2021年世界卫生组织与耐药性相关的复杂突变目录:基因型分析》
Lancet Microbe. 2022 Apr;3(4):e265-e273. doi: 10.1016/S2666-5247(21)00301-3.
5
Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004-2019.耐药结核病的危险因素、合并症状况与耐药模式之间的关系:中国山东 2004-2019 年既往治疗肺结核的回顾性研究。
BMJ Open. 2021 Jun 16;11(6):e044349. doi: 10.1136/bmjopen-2020-044349.
6
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis.药物诱导的结核分枝杆菌耐药机制。
Clin Microbiol Rev. 2020 Oct 14;34(1). doi: 10.1128/CMR.00141-20. Print 2020 Dec 16.
7
A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.2013 年至 2018 年中国东部地区异烟肼耐药结核病治疗结局和异烟肼耐药相关突变的回顾性队列研究。
J Glob Antimicrob Resist. 2020 Sep;22:847-853. doi: 10.1016/j.jgar.2020.07.012. Epub 2020 Jul 30.
8
A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus.一种预测结核病合并 2 型糖尿病患者抗结核药物耐药的新型危险因素。
Int J Infect Dis. 2020 Aug;97:69-77. doi: 10.1016/j.ijid.2020.05.080. Epub 2020 May 29.
9
Drug resistance of previously treated tuberculosis patients with diabetes mellitus in Shandong, China.中国山东治疗过的糖尿病合并结核病患者的耐药情况。
Respir Med. 2020 Mar;163:105897. doi: 10.1016/j.rmed.2020.105897. Epub 2020 Feb 7.
10
Diabetes is associated with genotypically drug-resistant tuberculosis.糖尿病与基因型耐药性肺结核有关。
Eur Respir J. 2020 Mar 20;55(3). doi: 10.1183/13993003.01891-2019. Print 2020 Mar.